A multitude of studies have shown that PDPN expression is increased in cancer and frequently correlates with poor prognosis, suggesting an important role for this protein in cancer progression and/or immunoevasion, and pointing towards PDPN as a potential target for cancer therapeutics. The gene discussed is PDPN; the disease is cancer.